Fidelity Investments
ORGS

Fidelity Investments’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Fidelity Investments’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-48
Closed -$2K – 4305
2019
Q2 		$2K Buy
+48
New +$2.17K ﹤0.01% 3560
2018
Q4 		– Sell
-15
Closed -$1K – 4264
2018
Q3 		$1K Buy
+15
New +$1.01K ﹤0.01% 3467

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCM
Venator Capital Management Toronto, Ontario, Canada $48.7M AUM 87.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.25B AUM 19.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments's ORGS Position: Q3 2019 in Review

Fidelity Investments sold out of Orgenesis Inc. Common Stock (ORGS) in Q3 2019, closing a stake of 48 shares — an estimated $2K sold.

Fidelity Investments first reported a position in ORGS in Q3 2018 and held it in 2 quarters. The position peaked at $2K in Q2 2019. 18 funds tracked by Wall St. Rank hold ORGS as of Q3 2019.

  • Fidelity Investments reported no remaining Orgenesis Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Fidelity Investments sold 48 Orgenesis Inc. Common Stock shares in Q3 2019, an estimated $2K.
  • Fidelity Investments first reported a position in Orgenesis Inc. Common Stock in Q3 2018 and held it in 2 quarters.
  • Fidelity Investments's Orgenesis Inc. Common Stock position peaked at $2K in Q2 2019.
  • 18 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q3 2019.

Based on Fidelity Investments's 13F filing for Q3 2019, filed 13 Nov 2019.